JENNIFER EKERN: Open Payments
NPI 1598478331 · JAMESTOWN, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$232 in 13 payments from 6 companies in 2025. Trend: 2023 $426 · 2024 $399 · 2025 $232
Food & beverage: $232
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 6 | $92 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Alkermes, Inc. | 1 | $17 |
Products named: INVEGA SUSTENNA, UZEDY, ABILIFY ASIMTUFII, TRINTELLIX, FANAPT, ARISTADA.
Industry payments across ND — which companies pay providers there.
